Page last updated: 2024-10-30

losartan and MELAS

losartan has been researched along with MELAS in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rajendran, PR1
Molitor, JA1

Other Studies

1 other study available for losartan and MELAS

ArticleYear
Resolution of hypertensive encephalopathy and scleroderma renal crisis with an angiotensin receptor blocker.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2005, Volume: 11, Issue:4

    Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; CADASIL; Female; Humans; Hypertensive

2005